You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

A Health Outcome Assessment of the Cardio Metabolic Mission Health Program at Novartis

Mauceri, Edward MD; Bienkowski, Catherine RN; Hanson, Kristin A. PharmD; Doyle, Joseph J. RPh, MBA; Jackson, James PharmD, MPH; Bramer, Susan MS

Journal of Occupational & Environmental Medicine:
doi: 10.1097/JOM.0b013e31821b7ade
Original Articles

Objective: To assess the impact of the Novartis Cardio Metabolic Program—an education, awareness, and health management initiative—on hypertension, hyperlipidemia, diabetes mellitus, and obesity within the Novartis employee population.

Methods: A prospective, 6-month pre-/post assessment to determine improvement in blood pressure (BP) control and risk factors after implementation of Novartis Cardio Metabolic.

Results: A total of 238 subjects with cardiovascular risk factors participated. In the hypertension cohort, overall BP control improved from 38% at baseline to 79% at follow-up (P < 0.0001). In the hyperlipidemia cohort, low-density lipoprotein cholesterol control improved significantly between baseline and study end (22% to 34%, P = 0.0004). In the diabetes mellitus cohort, the rate of glycosylated hemoglobin control increased from 83.7% to 86.2% (P = 0.69). There was a significant decrease in body mass index at follow-up (P < 0.0001).

Conclusion: Novartis Cardio Metabolic educational and health interventions helped to improve health awareness among Novartis employees.

Author Information

From Novartis Pharmaceuticals (Drs Mauceri and Hanson, Ms Bienkowski, and Mr Doyle), East Hanover, NJ; and Xcenda (Dr Jackson and Ms Bramer), Palm Harbor, Fla.

Address correspondence to: Susan Bramer, MS, Xcenda, LLC, 4114 Woodlands Parkway, Suite 500, Palm Harbor, FL 34685 (

Funding for this work was provided by Novartis Pharmaceuticals.

©2011The American College of Occupational and Environmental Medicine